Facing the world, win-win cooperation | Weixinkang Pharmaceutical at the 2024 Egyptian International Pharmaceutical Exhibition (Pharmaconex CPHI)

When the golden autumn of September 2024 meets Cairo full of ancient civilization, the 2024 Egyptian International Pharmaceutical Exhibition (Pharmaconex CPHI) is also about to arrive. The exhibition is the largest professional pharmaceutical industry exhibition in Africa, is the African market's pharmaceutical professional event, from the global pharmaceutical raw material industry and the Middle East, North Africa and other places of preparation leaders gathered here.

Xizang Weixinkang Pharmaceutical Co., LTD., as the leading brand of parenteral nutrition medicine in China and the leader of trace element raw materials in China, deeply participated in this event, fully demonstrating the company's leading technological advantages in the field of trace elements, vitamins, electrolytes, amino acids and other parenteral nutrition preparations and raw materials, and demonstrating the strength of Chinese brands to promote overseas. With the characteristics of high quality products and a full range of cooperation mode to attract many overseas customers to visit the attention.

Exhibition negotiation and harvest results

During the exhibition, the company's booth attracted customers from Zimbabwe, Sudan, Jordan, Iraq, Pakistan, Egypt, Saudi Arabia, Yemen, Vietnam and other more than 10 countries to come to negotiate, jointly discuss the comprehensive product series of Weixinkang, the industry's new technology trends and future development trend, all-round, multi-angle collection of effective market resources and information, In-depth understanding of the market demand, achieved the expected results. The face-to-face communication also deepened overseas customers' brand awareness of Weixinkang's in-depth innovation and development in the field of characteristic fields, and also gave a high degree of affirmation and recognition to the company's integrity innovation in the field of parenteral nutrition preparations, especially the four characteristic series of products and technologies of children's parenteral nutrition preparations.

Promote official exchanges and cooperation

During the exhibition, members of the company's delegation also contacted the Egyptian Medicines Administration (EDA) and the Egyptian Unified Procurement, Medical Supply and Technology Authority (AUPP) to conduct business talks and learn more about local policies, regulations, market dynamics and local cooperation opportunities for the company's products. We discussed with PHARCO, the top generic drug company in Egypt, on the joint production of the company's parenteral nutrition preparations in Egypt and the joint development of the Egyptian and Middle East and North Africa markets and the feasibility assessment.

Look to the future

This exhibition is not only an opportunity for Weixinkang's core products to appear in overseas markets, but also an important moment for the company to explore how to achieve product internationalization and high-quality development. Looking forward to the future, Weixinkang will continue to focus on meeting clinical and market needs, continue to strengthen the global operation system of research and development, production and commercialization, fully accelerate the process of internationalization, continue to deepen international strategic cooperation, and strive to become a trusted partner of global biopharmaceutical enterprises, benefiting more patients around the world with leading technology and excellent quality.